---
$id: https://graph.org.ai/products/commodity/51131635
$type: Product
source: UNSPSC
code: "51131635"
title: "Ecraprost"
class: "51131600"
classTitle: "Anticoagulants"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ecraprost

**UNSPSC Code**: 51131635
**Class**: [Anticoagulants](Anticoagulants.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiplatelet agent with the molecular formula C28H48O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q2XM6VR8DO, chemically known as prosta-8,13-dien-1-oic acid, 11,15-dihydroxy-9-(1-oxobutoxy)-, butyl ester, (11 alpha, 13e,15s)- but generally known as ecraprost, which bears US NIH Compound Identifier 6441614. The term ECRAPROST is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 No. 1, 2001, List 45). Most nations schedule ecraprost under HS 29375000 and SITC 54156. As of Q4 2014, ECRAPROST remains the US FDA Preferred Term for this commodity. Ecraprost bears US NLM identifiers UMLS ID C0671097 and NCI Concept Code C76397. SMILES: CCCCCC(C=CC1C(CC(=C1CCCCCCC(=O)OCCCC)OC(=O)CCC)O)O.

